Citation tools
"Abstract A009: Forty-three week follow-up of a phase 1a clinical trial of a PSA, IL-2, GM-CSF containing prostate cancer therapeutic vaccine in PSA defined biochemical recurrent prostate cancer patients." Cancer Immunology Research
7.2 Supplement
(2019):
A009.
Web. 08 Mar. 2021.